BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11697624)

  • 21. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
    Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M
    Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
    Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of Musculoskeletal Manifestations as the Only Presenting Symptom in B-Cell Acute Lymphoblastic Leukemia.
    Kang S; Im HJ; Bae K; Park SS
    J Pediatr; 2017 Mar; 182():290-295.e1. PubMed ID: 28063690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low expressions of ARS2 and CASP8AP2 predict relapse and poor prognosis in pediatric acute lymphoblastic leukemia patients treated on China CCLG-ALL 2008 protocol.
    Cui L; Gao C; Zhang RD; Jiao Y; Li WJ; Zhao XX; Liu SG; Yue ZX; Zheng HY; Deng GR; Wu MY; Li ZG; Jia HT
    Leuk Res; 2015 Feb; 39(2):115-23. PubMed ID: 25530566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
    zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
    Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The BCL-2 protein in precursor B acute lymphoblastic leukemia in children.
    Chaber R; Fiszer-Maliszewska L; Noworolska-Sauren D; Kwasnicka J; Wrobel G; Chybicka A
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):180-7. PubMed ID: 23511489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia.
    Del Principe MI; Del Poeta G; Maurillo L; Buccisano F; Venditti A; Tamburini A; Bruno A; Cox MC; Suppo G; Tendas A; Giannì L; Postorino M; Masi M; Del Principe D; Amadori S
    Br J Haematol; 2003 Jun; 121(5):730-8. PubMed ID: 12780787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse.
    Stamati L; Avgeris M; Kosmidis H; Baka M; Anastasiou T; Piatopoulou D; Scorilas A; Gourgiotis D
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):2023-36. PubMed ID: 25982455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia.
    Sauerbrey A; Häfer R; Zintl F; Volm M
    Anticancer Res; 1999; 19(1B):645-9. PubMed ID: 10216470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Bcl-2-siRNA on proliferation and apoptosis of pediatric acute B lymphoblastic leukemia (A-BLL) cells.
    Meng WB; Liu JP; Wang XW; E LH
    Genet Mol Res; 2015 Oct; 14(4):12427-36. PubMed ID: 26505392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified "New York" protocols (1987-2003)].
    Kwiecińska K; Balwierz W; Moryl-Bujakowska A; Wachowiak J; Derwich K; Matysiak M; Pawelec K; Chybicka A; Dobaczewski G; Kowalczyk JR; Wiśniewska-Slusarz H; Sońta-Jakimczyk D; Szczepański T; Tomaszewska R; Wysocki M; Styczyński J; Balcerska A; Płoszyńska A
    Przegl Lek; 2010; 67(6):350-4. PubMed ID: 21344760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia.
    Bhadri VA; Trahair TN; Lock RB
    J Paediatr Child Health; 2012 Aug; 48(8):634-40. PubMed ID: 22050419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of p53 and Bcl-2 in acute lymphoblastic leukemia.
    Sahu GR; Das BR
    Oncol Rep; 2002; 9(6):1391-8. PubMed ID: 12375054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia.
    Styczynski J; Piatkowska M; Jaworska-Posadzy A; Czyzewski K; Kubicka M; Kolodziej B; Kurylo-Rafinska B; Debski R; Pogorzala M; Wysocki M
    Anticancer Res; 2012 Dec; 32(12):5495-9. PubMed ID: 23225457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.
    Wang Y; Zeng HM; Zhang LP
    Ital J Pediatr; 2018 Aug; 44(1):94. PubMed ID: 30115129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse.
    Núñez-Enríquez JC; Bárcenas-López DA; Hidalgo-Miranda A; Jiménez-Hernández E; Bekker-Méndez VC; Flores-Lujano J; Solis-Labastida KA; Martínez-Morales GB; Sánchez-Muñoz F; Espinoza-Hernández LE; Velázquez-Aviña MM; Merino-Pasaye LE; García Velázquez AJ; Pérez-Saldívar ML; Mojica-Espinoza R; Ramírez-Bello J; Jiménez-Morales S; Mejía-Aranguré JM;
    Arch Med Res; 2016 Nov; 47(8):644-655. PubMed ID: 28476192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study.
    Klobusická M; Kusenda J; Babusíkova O
    Neoplasma; 2001; 48(6):489-95. PubMed ID: 11949843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of glucocorticoid induction test in Chinese childhood acute lymphoblastic leukemia].
    Fan JJ; Chai YH; Hu SY; He HL; Zhao WL; Wang Y; Li J; Lu J; Xiao PF; Sun YN; Wang W; Cao L
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):523-6. PubMed ID: 24267134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.